Check-Cap Ltd. Ordinary Share
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $10.9M
- Price
- $8.04
- % Change (Daily % change from the live per-ticker quote feed.)
- +0.25%
- Volume
- 4.4K
About
Check-Cap Ltd. is a medical diagnostics entity currently in its clinical development phase, dedicated to advancing screening solutions that utilize capsule-based technology. This firm was established in 2004 and conducts its primary operations from Isfiya, Israel.
Quick stats
Shares outstanding1.4M
Computed float651.1K
Float / shares48.2%
Key info
SectorHealthcare
IndustryMedical - Diagnostics & Research
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001610590
Websitehttps://check-cap.com
AI Summary
AI-generated1/13
majorbearishreverse split
Check-Cap (MBAI) Advances Merger with MBody AI; Reverse Share Split Effective
Check-Cap's 1-for-7 reverse share split is effective as of August 13, 2026, reducing outstanding ordinary shares from approximately 9.46 million to 1.35 million.
The corporate action is a proactive measure to satisfy the $4.00 minimum bid price requirement for the combined company's initial listing application following its proposed merger with MBody AI.
The merger with the physical AI company remains on track for closure in the third quarter of 2026, subject to final Nasdaq approval and customary closing conditions.
Red flags
- Reverse split signals listing compliance risk
- Merger completion is subject to final Nasdaq approval and customary closing conditions